Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 770 JPY 2.37% Market Closed
Market Cap: 44.1B JPY

Fuji Pharma Co Ltd
Total Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Fuji Pharma Co Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Total Liabilities
ÂĄ48B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
10%
Takeda Pharmaceutical Co Ltd
TSE:4502
Total Liabilities
ÂĄ7.3T
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
Total Liabilities
ÂĄ1.9T
CAGR 3-Years
26%
CAGR 5-Years
21%
CAGR 10-Years
12%
Otsuka Holdings Co Ltd
TSE:4578
Total Liabilities
ÂĄ1.1T
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Total Liabilities
ÂĄ232.3B
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
5%
Astellas Pharma Inc
TSE:4503
Total Liabilities
ÂĄ1.8T
CAGR 3-Years
25%
CAGR 5-Years
15%
CAGR 10-Years
15%
No Stocks Found

Fuji Pharma Co Ltd
Glance View

Market Cap
43.2B JPY
Industry
Pharmaceuticals

Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,532 full-time employees. The firm is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.

Intrinsic Value
2 291.35 JPY
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Fuji Pharma Co Ltd's Total Liabilities?
Total Liabilities
48B JPY

Based on the financial report for Jun 30, 2025, Fuji Pharma Co Ltd's Total Liabilities amounts to 48B JPY.

What is Fuji Pharma Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
10%

Over the last year, the Total Liabilities growth was 10%. The average annual Total Liabilities growth rates for Fuji Pharma Co Ltd have been 8% over the past three years , 16% over the past five years , and 10% over the past ten years .

Back to Top